GlassScriptPhysician profile
Michael Castellano
NPI 1417957572
$7,387.68
in general payments reported to CMS, 2019-2025
26 companies · $1,168 in 2025
The $1,168 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,884 · 2020: $681 · 2021: $986 · 2022: $973 · 2023: $623 · 2024: $1,073 · 2025: $1,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,864.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,596.91 | 2019-2025 | Apligraf, Puraply, Puraply Am |
| Ethicon INC. | $1,538.40 | 2019 | |
| Smith+Nephew, INC. | $1,227.88 | 2019-2025 | Collagenase Santyl, Oasis, Pico |
| Tactile Systems Technology INC | $819.67 | 2019-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Misonix INC | $430.67 | 2019-2021 | |
| Integra Lifesciences Corporation | $430.26 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Solventum Corporation | $182.67 | 2024-2025 | Activ.A.C., Prevena Restor Axioform, V.A.C. Dermatac |
| Davol INC. | $179.41 | 2020 | |
| Medline Industries LP | $160.98 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $150.55 | 2019-2025 | Caldolor, Vibativ |
| Hydrofera LLC | $146.61 | 2022-2023 | Hydrofera Blue, Cutimed Sorbact |
| Bioventus LLC | $125.51 | 2022 | |
| 180 Medical, INC. | $44.70 | 2024-2025 | Juzo Compression Wrap, Juzo Basic |
| Paratek Pharmaceuticals, INC. | $40.47 | 2024 | Nuzyra |
| Kci USA, INC. | $39.05 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $36.13 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Avita Medical Americas, LLC | $35.20 | 2025 | Permeaderm, Recell, Cohealyx |
| Abbvie INC. | $31.65 | 2024 | |
| Convatec INC. | $30.26 | 2022 | |
| Intuitive Surgical, INC. | $25.17 | 2023 | |
| Myriad Genetic Laboratories, INC. | $24.91 | 2025 | Myrisk |
| Lifenet Health | $23.80 | 2023 | |
| Janssen Pharmaceuticals, INC | $19.29 | 2022 | |
| Advanced Oxygen Therapy INC. | $17.78 | 2025 | Topical Oxygen Chamber For Extremities |
| Novo Nordisk INC | $15.83 | 2024 | Rybelsus, Ozempic |
| Acell, INC. | $13.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Castellano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.